Functional Group Analysis of Andrographis paniculata by FT IR Spectrum
نویسندگان
چکیده
منابع مشابه
Structural Analysis of Hirudin Using FT-IR and FT-Raman Spectroscopic Techniques
FT-IR and FT-Raman spectra of hirudin have been recorded from the native solid hirudin. The conformation of the molecule has been discussed on the basis of IR and Raman data. It has been concluded that hirudin molecule has a mixed a-helix and random coil conformation.
متن کاملPerspective of Andrographis paniculata in Neurological Disorders
Andrographis paniculata (Burm. F.) Wall. Ex Nees (family Acanthaceae) also known as Kalmegh (Figure 1), is extremely bitter in taste and it is often referred to as the “the king of bitters”. This plant has been used as bitter tonic, stimulant, and aperients in Ayurvedic and other traditionally known health care systems widely practiced in India and other Asiatic countries. Amongst numerous plan...
متن کاملReview on Phytopharmacological Activities of Andrographis Paniculata
Medicinal plants are in prevalence from the origin of the earth which has been efficiently used by ancient people as a cure for various ailments. The plant extracts are identified and act as an important source of active ingredient and secondary metabolite products such as alkaloid, terpenoids, which is used in curing diseases, for drug production and perpetuating good health by both the tradit...
متن کاملIs Andrographis paniculata extract and andrographolide anaphylactic?
Andrographis paniculata, "King of bitters" is a popularly known medicinal plant extensively used in many parts of the world for treatment of various diseases. Since recent past, anaphylactic/allergic type adverse events were reported upon A. paniculata usage, the study aimed to evaluate the anaphylactic and anaphylactoid potential of A. paniculata extract and andrographolide (a major phytoactiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Research Journal of Pharmacol.
سال: 2019
ISSN: 1815-9362
DOI: 10.36478/rjpharm.2019.27.31